Dr. Vinciguerra’s new research confirms that undesireable effects are rare. Previous research by his group indicated no loss of corneal endothelial cell, a measurement utilized to assess the protection of corneal treatments, in individuals who received collagen crosslinking. Related StoriesRXi Pharmaceuticals starts Phase 1/2 clinical trial in ophthalmologyResearchers discover ranibizumab drug as effective option to laser therapy for treating diabetic retinopathyAAO recognizes exceptional eye physicians and surgeons for invention in patient treatment’For many people with keratoconus, collagen crosslinking can provide a better and more permanent answer to their vision complications,’ said Dr.‘In the event that’s what the patient’s mindset is usually he’s likely going to come back and say, I wasn’t getting enough relief and I doubled the prescription,’ she said. Dr. Stephen Loyd informed CBS Information that as a physician actually, he fell victim to the cycle. Loyd was within the last 12 months of his residency when he started taking prescription painkillers which were leftover from a dental care procedure. Loyd has since recovered and shares his tale with others now. He got treatment, resumed his medical profession and has been clean for a decade. The federal government has unveiled new efforts to curb prescription drug abuse also. The company in Oct. Recommended reclassifying Vicodin as a harder medication, calling for this to be put into the same category as Oxycontin.